Aeluma Financials
Aeluma (ALMU) reported $5.2M in revenue over the twelve months to Mar 31, 2026, up 43.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financing, not operations, is driving the balance-sheet expansion as Aeluma shifts from development spending toward commercial scale.
The important change is the combination of revenue scaling from$919K in FY2024 to$4.7M in FY2025 while gross margin widened to59.6% ; this suggests improving production economics rather than growth alone. Yet FY2025 operating cash flow remained-$1.1M against a net loss of-$3.0M , showing that accounting losses still overstate the cash consumed by the business.
FY2025 financing supplied
Development spending became less dominant: R&D fell from
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Aeluma's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Aeluma has an operating margin of -45.9%, meaning the company loses $46 on every $100 of revenue. This results in a profitability score of 11/100. This is up from -496.5% the prior year.
Not available for Aeluma, and counted as zero in the overall score.
Aeluma carries a low D/E ratio of 0.08, meaning only $0.08 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 81/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 24.59, Aeluma holds $24.59 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 99/100.
Aeluma's operations used $1.1M of cash, and capex of $161K added to the outflow, for a free cash flow shortfall of $1.3M. This results in a cash flow score of 11/100.
Aeluma posts a -16.9% return on equity (ROE), meaning it loses $17 for every $100 of shareholders' equity. This results in a returns score of 20/100. This is up from -200.4% the prior year.
Aeluma scores 90.45, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($228.1M) relative to total liabilities ($1.5M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Aeluma passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.
Aeluma reported a net loss of $3.0M while operations used $1.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Aeluma generated $4.7M in revenue in fiscal year 2025. This represents an increase of 407.6% from the prior year.
Aeluma's EBITDA was -$1.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 59.4% from the prior year.
Aeluma reported -$3.0M in net income in fiscal year 2025. This represents an increase of 33.8% from the prior year.
Aeluma earned -$0.23 per diluted share (EPS) in fiscal year 2025. This represents an increase of 37.8% from the prior year.
Cash & Balance Sheet
Aeluma recorded an outflow of $1.3M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents an increase of 65.3% from the prior year.
Aeluma held $3.6M in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Margins & Returns
Aeluma's gross margin was 59.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 27.0 percentage points from the prior year.
Aeluma's operating margin was -45.9% in fiscal year 2025, reflecting core business profitability. No change is given against fiscal year 2024: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Aeluma's net profit margin was -64.8% in fiscal year 2025, showing the share of revenue converted to profit. No change is given against fiscal year 2024: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Aeluma's ROE was -16.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 183.6 percentage points from the prior year.
Capital Allocation
Aeluma invested $1.3M in research and development in fiscal year 2025. This represents a decrease of 48.3% from the prior year.
Aeluma invested $161K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 50.0% from the prior year.
Not reported for fiscal year 2025.
ALMU Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.2M-3.9% | $1.3M-8.2% | $1.4M+5.2% | $1.3M+4.9% | $1.3M-22.1% | $1.6M+235.1% | $481K+72.0% | $280K |
| Cost of Revenue | $836K-9.0% | $919K+31.1% | $701K+4.0% | $674K+116.7% | $311K-46.7% | $584K+85.4% | $315K+34.9% | $234K |
| Gross Profit | $386K+9.3% | $353K-48.4% | $684K+6.4% | $643K-31.9% | $944K-8.2% | $1.0M+519.3% | $166K+259.3% | $46K |
| R&D Expenses | $882K-2.6% | $906K+49.5% | $606K+291.0% | $155K-67.1% | $471K+75.7% | $268K-33.2% | $401K+0.1% | $401K |
| SG&A Expenses | $1.6M+6.6% | $1.5M-9.4% | $1.7M+15.8% | $1.5M+11.6% | $1.3M+251.8% | $371K-25.2% | $496K-21.8% | $634K |
| Operating Income | -$3.3M-60.8% | -$2.1M-29.4% | -$1.6M-660.3% | $287K+113.8% | -$2.1M-636.5% | $389K+153.2% | -$731K+26.1% | -$989K |
| Net Income | -$1.8M+2.9% | -$1.9M-24.1% | -$1.5M-74.0% | -$858K-158.7% | $1.5M+150.5% | -$2.9M-296.6% | -$730K+26.2% | -$989K |
| EPS (Diluted) | -$0.10+9.1% | -$0.11-22.2% | -$0.09-80.0% | -$0.05-145.5% | $0.11+145.8% | -$0.24-300.0% | -$0.06+25.0% | -$0.08 |
Not reported in any period shown, so not listed: Interest Expense, Income Tax.
ALMU Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $42.5M-0.1% | $42.6M-0.2% | $42.7M+119.8% | $19.4M+0.2% | $19.4M+186.5% | $6.8M+6.4% | $6.3M+65.2% | $3.8M |
| Current Assets | $40.2M-0.2% | $40.3M+0.1% | $40.2M+132.0% | $17.3M+0.6% | $17.2M+280.3% | $4.5M+12.5% | $4.0M+189.1% | $1.4M |
| Cash & Equivalents | $37.8M-2.1% | $38.6M+48.8% | $25.9M+614.4% | $3.6M-6.1% | $3.9M+26.2% | $3.1M-12.5% | $3.5M+171.3% | $1.3M |
| Accounts Receivable | $1.1M+6.2% | $1.0M-19.9% | $1.2M+29.7% | $962K-15.9% | $1.1M-13.7% | $1.3M+311.1% | $322K+437.0% | $60K |
| Total Liabilities | $2.4M+37.6% | $1.8M+0.4% | $1.8M+16.7% | $1.5M+10.5% | $1.4M-82.5% | $7.8M+68.1% | $4.6M+195.6% | $1.6M |
| Current Liabilities | $1.5M+86.5% | $825K+7.4% | $768K+8.9% | $705K+34.1% | $526K+7.6% | $489K-81.4% | $2.6M+319.6% | $627K |
| Total Equity | $40.1M-1.8% | $40.8M-0.2% | $40.9M+128.5% | $17.9M-0.6% | $18.0M+1842.2% | -$1.0M-160.3% | $1.7M-24.7% | $2.3M |
| Retained Earnings | -$21.8M-9.0% | -$20.0M-10.2% | -$18.1M-9.0% | -$16.6M-5.4% | -$15.8M+8.5% | -$17.2M-20.2% | -$14.4M-5.4% | -$13.6M |
Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.
ALMU Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$577K-129.9% | -$251K+69.2% | -$815K-1153.8% | -$65K-126.1% | $249K+162.1% | -$401K+56.9% | -$931K-60.8% | -$579K |
| Capital Expenditures | $198K+538.7% | $31K-85.2% | $210K+176.3% | $76K+72.7% | $44K+12.8% | $39K+1850.0% | $2K-60.5% | $5K |
| Free Cash Flow | -$775K-174.8% | -$282K+72.5% | -$1.0M-627.0% | -$141K-168.8% | $205K+146.6% | -$440K+52.8% | -$933K-59.8% | -$584K |
| Investing Cash Flow | -$198K-538.7% | -$31K+85.2% | -$210K-176.3% | -$76K-72.7% | -$44K-12.8% | -$39K-1850.0% | -$2K+60.5% | -$5K |
| Financing Cash Flow | -$17K-102.4% | $707K-97.0% | $23.4M+146350.0% | $16K-99.9% | $12.6M | $0-100.0% | $3.1M+314499900.0% | $1 |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$1 |
Not reported in any period shown, so not listed: Dividends Paid.
ALMU Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.6%+3.8pp | 27.8%-21.6pp | 49.4%+0.6pp | 48.8%-26.4pp | 75.2%+11.4pp | 63.8%+29.3pp | 34.5%+18.0pp | 16.5% |
| Operating Margin | -273.9% | -163.6% | -116.1% | 21.8% | -166.3% | 24.1% | -152.0% | -353.5% |
| Net Margin | -147.3% | -145.7% | -107.8% | -65.1% | 116.4% | -179.6% | -151.8% | -353.4% |
| Return on Equity | -4.5%+0.1pp | -4.5%-0.9pp | -3.6%+1.1pp | -4.8%-12.9pp | 8.1% | N/A | -42.6%+0.8pp | -43.4% |
| Return on Assets | -4.2%+0.1pp | -4.3%-0.8pp | -3.5%+0.9pp | -4.4%-12.0pp | 7.5%+50.4pp | -42.8%-31.3pp | -11.5%+14.2pp | -25.7% |
| Current Ratio | 26.10-22.7x | 48.80-3.6x | 52.38+27.8x | 24.59-8.2x | 32.76+23.5x | 9.27+7.7x | 1.53-0.7x | 2.22 |
| Debt-to-Equity | 0.060.0x | 0.040.0x | 0.040.0x | 0.080.0x | 0.08 | N/A | 2.71+2.0x | 0.69 |
| FCF Margin | -63.4%-41.3pp | -22.2%+51.8pp | -74.0%-63.3pp | -10.7%-27.0pp | 16.3%+43.6pp | -27.3% | -194.0% | -208.7% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Similar Companies
Where Aeluma Ranks
Frequently Asked Questions
What is Aeluma's annual revenue?
Aeluma (ALMU) reported $4.7M in total revenue for fiscal year 2025. This represents a 407.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Aeluma's revenue growing?
Aeluma (ALMU) revenue grew by 407.6% year-over-year, from $919K to $4.7M in fiscal year 2025.
Is Aeluma profitable?
No, Aeluma (ALMU) reported a net income of -$3.0M in fiscal year 2025, with a net profit margin of -64.8%.
What is Aeluma's EBITDA?
Aeluma (ALMU) had EBITDA of -$1.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Aeluma's gross margin?
Aeluma (ALMU) had a gross margin of 59.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Aeluma's operating margin?
Aeluma (ALMU) had an operating margin of -45.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Aeluma's net profit margin?
Aeluma (ALMU) had a net profit margin of -64.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Aeluma's return on equity (ROE)?
Aeluma (ALMU) has a return on equity of -16.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Aeluma's free cash flow?
Aeluma (ALMU) recorded an outflow of $1.3M in free cash flow during fiscal year 2025. This represents a 65.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Aeluma's operating cash flow?
Aeluma (ALMU) recorded an outflow of $1.1M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Aeluma's total assets?
Aeluma (ALMU) had $19.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Aeluma's capital expenditures?
Aeluma (ALMU) invested $161K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Aeluma spend on research and development?
Aeluma (ALMU) invested $1.3M in research and development during fiscal year 2025.
What is Aeluma's current ratio?
Aeluma (ALMU) had a current ratio of 24.59 as of fiscal year 2025, which is generally considered healthy.
What is Aeluma's debt-to-equity ratio?
Aeluma (ALMU) had a debt-to-equity ratio of 0.08 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Aeluma's return on assets (ROA)?
Aeluma (ALMU) had a return on assets of -15.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
How does Aeluma's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Aeluma (ALMU) held $3.6M in cash, cash equivalents and investments, and reported an operating cash outflow of $1.1M over that year. Dividing the one by the other, the reported balance equals about 38 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Aeluma's Altman Z-Score?
Aeluma (ALMU) has an Altman Z-Score of 90.45, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Aeluma's Piotroski F-Score?
Aeluma (ALMU) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Aeluma's earnings high quality?
Aeluma (ALMU) reported a net loss of $3.0M while operations used $1.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Aeluma?
Aeluma (ALMU) scores 37 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.